SNYNF Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 May 2024 @ 11:51):

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally...

Stats
Today's Volume	672.00
Average Volume	26 596.00
Market Cap	118.08B
EPS	$2.55 ( 2023-10-26 )
Next earnings date	( $1.720 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	22.16
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2014-07-10	Sanofi	Buy	17 286	Common Stock
2014-07-10	Sanofi	Buy	18 057	Common Stock
2014-07-10	Sanofi	Buy	20 638	Common Stock
2014-07-10	Sanofi	Buy	15 815	Common Stock
2014-07-10	Sanofi	Buy	53 994	Common Stock

INSIDER POWER
0.00
Last 9 transactions
Buy: 175 000 \| Sell: 0

Sanofi Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sanofi Financials

Annual	2023
Revenue:	$43.07B
Gross Profit:	$26.50B (61.52 %)
EPS:	$4.31

FY	2023
Revenue:	$43.07B
Gross Profit:	$26.50B (61.52 %)
EPS:	$4.31

FY	2022
Revenue:	$45.39B
Gross Profit:	$31.70B (69.83 %)
EPS:	$6.69

Financial Reports:

No articles found.

Sanofi

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.